NeuClone to Initiate Phase I Clinical Trial of Stelara Ustekinumab Biosimilar the Second Biosimilar from the 10product Portfolio with Serum Institute

SYDNEY May 15 2019 PRNewswire NeuClone Pharmaceuticals Ltd. NeuClone a clinicalstage biopharmaceutical company exclusively focused on developing highquality biosimilar products today announced it will initiate the Phase I clinical trial of its Stelara&am...